Yuyu Zhu, Ning Wan, Xinni Shan, Guoliang Deng, Qiang Xu, Hui Ye, Yang Sun. Author correction to “Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice” Acta Pharm Sin B 11 (2021) 1200-1212J. Acta Pharmaceutica Sinica B, 2025, 15(3): 1719-1720. DOI: 10.1016/j.apsb.2024.12.009
|
Citation:
|
Yuyu Zhu, Ning Wan, Xinni Shan, Guoliang Deng, Qiang Xu, Hui Ye, Yang Sun. Author correction to “Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice” Acta Pharm Sin B 11 (2021) 1200-1212J. Acta Pharmaceutica Sinica B, 2025, 15(3): 1719-1720. DOI: 10.1016/j.apsb.2024.12.009
|
Yuyu Zhu, Ning Wan, Xinni Shan, Guoliang Deng, Qiang Xu, Hui Ye, Yang Sun. Author correction to “Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice” Acta Pharm Sin B 11 (2021) 1200-1212J. Acta Pharmaceutica Sinica B, 2025, 15(3): 1719-1720. DOI: 10.1016/j.apsb.2024.12.009
|
Citation:
|
Yuyu Zhu, Ning Wan, Xinni Shan, Guoliang Deng, Qiang Xu, Hui Ye, Yang Sun. Author correction to “Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice” Acta Pharm Sin B 11 (2021) 1200-1212J. Acta Pharmaceutica Sinica B, 2025, 15(3): 1719-1720. DOI: 10.1016/j.apsb.2024.12.009
|
DownLoad: